Rymedi, a Greenville-based healthcare software company, announced it has closed a $9 million Series A financing round.
The financing will be used to expand the company’s healthcare data exchange platform which uses advanced blockchain security to:
- Automate data transfers
- Streamline data entry with real-time results
- Meet global regulatory compliance standards
Specifically, the funds will help increase data security and healthcare record accessibility for patients using the company’s platform. Data entry errors and costs for global-scale healthcare data infrastructures will also be reduced.
“We are improving the overall healthcare experience with this technology and are proud to make a larger global impact as we scale our services with this round of funding,” said David Stefanich, Rymedi’s CEO and founder.
Co-led by RW3 Ventures and White Star Capital, the financing round received participation from Blockchange Ventures, Avalanche’s Blizzard Fund and strategic angel investors from the healthcare industry.
“We are always searching for great teams that are using blockchain technology to solve real-world problems with the potential to address global markets,” said Pete Najarian, managing partner of RW3 Ventures. “The Rymedi team and product suite fit that thesis perfectly, and we are delighted to be on this journey with them.”
Rymedi serves more than one million patients in over 1,200 locations across the United States, Africa and Australia. Data for laboratories, occupational health, healthcare systems and clinical trials data can be transferred using the company’s software.
